The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cell

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cell.2010.01.026PMID 20211139PMCID PMC2843143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction to “Fragile X Syndrome”

  2011influential reference
• Heterosynaptic molecular dynamics: locally induced propagating synaptic accumulation of CaM kinase II.

  2009cited by this paper
• Synaptic AMPA receptor plasticity and behavior.

  2009cited by this paper
• Autism genome-wide copy number variation reveals ubiquitin and neuronal genes

  2009cited by this paper
• Ube3a is required for experience-dependent maturation of the neocortex

  2009influential reference
• Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD.

  2008cited by this paper
• SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome.

  2008influential reference
• Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection.

  2008cited by this paper
• From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function.

  2008influential reference
• Activity-dependent regulation of inhibitory synapse development by Npas4

  2008cited by this paper
• Identifying Autism Loci and Genes by Tracing Recent Shared Ancestry

  2008cited by this paper
• Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome

  2008cited by this paper
• Glutamate receptor dynamics in dendritic microdomains.

  2008cited by this paper
• The mouse polyubiquitin gene UbC is essential for fetal liver development, cell‐cycle progression and stress tolerance

  2007influential reference
• Faculty Opinions recommendation of Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation.

  2007cited by this paper
• Regulation of {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking through PKA phosphorylation of the Glu receptor 1 subunit.

  2007cited by this paper
• Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors

  2007cited by this paper
• Correction of fragile X syndrome in mice.

  2007cited by this paper
• Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits.

  2007influential reference
• An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development.

  2007cited by this paper
• Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation

  2007cited by this paper
• Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors.

  2006influential reference
• Angelman syndrome 2005: Updated consensus for diagnostic criteria

  2006influential reference
• Activity-Dependent Regulation of MEF2 Transcription Factors Suppresses Excitatory Synapse Number

  2006cited by this paper
• Enriched environments, experience-dependent plasticity and disorders of the nervous system

  2006cited by this paper
• Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking.

  2006influential reference
• Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.

  2006cited by this paper
• Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission.

  2006influential reference
• Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

  2005influential reference
• Vav family GEFs link activated Ephs to endocytosis and axon guidance.

  2005cited by this paper
• Biochemical Analysis of Angelman Syndrome-associated Mutations in the E3 Ubiquitin Ligase E6-associated Protein*

  2004cited by this paper
• Structure of the XPC binding domain of hHR23A reveals hydrophobic patches for protein interaction

  2004cited by this paper
• Ephrin-A1 Induces c-Cbl Phosphorylation and EphA Receptor Down-Regulation in T Cells1

  2003influential reference
• Angelman syndrome: a review of the clinical and genetic aspects

  2003cited by this paper
• Genetics of childhood disorders: XLVII. Autism, part 6: duplication and inherited susceptibility of chromosome 15q11-q13 genes in autism.

  2003cited by this paper
• Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2

  2003cited by this paper
• Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.

  2002cited by this paper
• ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF

  2000cited by this paper
• Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination.

  1999cited by this paper
• Identification of HHR23A as a Substrate for E6-associated Protein-mediated Ubiquitination*

  1999cited by this paper
• Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

  1998influential reference
• Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons

  1997cited by this paper
• Autism or atypical autism in maternally but not paternally derived proximal 15q duplication.

  1997cited by this paper
• De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome

  1997cited by this paper
• UBE3A/E6-AP mutations cause Angelman syndrome

  1996cited by this paper
• Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

  1995cited by this paper
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993influential reference

• Ubiquitination of Metabotropic Glutamate Receptors and Associated Synaptic Proteins In Vitro and In Vivo

  2026cites this paper
• Genetics of Autism Spectrum Disorder underscores the role of altered spontaneous neuronal activity as a catalyst for the neurodevelopmental anomalies.

  2026cites this paper
• RNAi-Induced Expression of Paternal UBE3A.

  2026cites this paper
• ARSACS: Clinical Features, Pathophysiology and iPS-Derived Models

  2025cites this paper
• Environmental context modulates sociability in ube3a zebrafish mutants via alterations in sensory pathways

  2025cites this paper
• Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System

  2025cites this paper
• Mutation of ube3a causes developmental abnormalities and autism-like molecular and behavioral alterations in zebrafish.

  2025cites this paper
• Transcriptomic analysis identifies muscle-specific mitochondrial and vesicular transport genes as methylmercury toxicity targets in a Drosophila model of Congenital Minamata Disease.

  2025cites this paper
• AMPA receptors in the evolving synapse: structure, function, and disease implications

  2025cites this paper
• Cofilin Inhibition Ameliorates PIEZO2 and AMPA Dysfunction in a Mouse Model of Angelman Syndrome

  2025cites this paper
• Dysregulation of neuronal activity-dependent immediate early genes in a mouse model of Angelman syndrome

  2025influential citation
• Behavioral and molecular insights into anxiety in ube3a and fmr1 zebrafish models of autism spectrum disorders

  2025cites this paper
• Perinatal Choline Supplementation Promotes Resilience Against Progression of Alzheimer's Disease‐Like Brain Transcriptomic Signatures in App NL‐G‐F Mice

  2025cites this paper
• Protein quality control systems in neurodegeneration – culprits, mitigators, and solutions?

  2025cites this paper
• Activity-dependent degradation of Kv4.2 contributes to synaptic plasticity and behavior in Angelman syndrome model mice.

  2025cites this paper
• The Ubiquitin E3 Ligase UBE3A Regulates GRIPAP1 and PACSIN1 Proteins Linked to the Endocytic Recycling of AMPA Receptors

  2025cites this paper
• Dysregulated RNA-binding proteins and alternative splicing: Emerging roles in autism spectrum disorder

  2025cites this paper
• UBQLN2 facilitates degradation of the retrotransposon protein PEG10 via UBE3A activity

  2025cites this paper
• Role of androgen receptors in sexually dimorphic phenotypes in UBE3A-dependent autism spectrum disorder

  2025cites this paper
• Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications

  2025cites this paper
• The Ubiquitin–Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers

  2025cites this paper
• Acute administration of lovastatin had no pronounced effect on motor abilities, motor coordination, gait nor simple cognition in a mouse model of Angelman syndrome

  2025cites this paper
• Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration

  2025cites this paper
• Extracellular vesicle dysfunction contributes to synaptic and cognitive deficits in a mouse model of Angelman syndrome.

  2025cites this paper
• Identification of E3 Ubiquitin Ligase Substrates Using Biotin Ligase-Based Proximity Labeling Approaches

  2025cites this paper
• The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial

  2025cites this paper
• A High Sensitivity Assay of UBE3A Ubiquitin Ligase Activity

  2025cites this paper
• UBQLN2 is necessary for UBE3A-mediated proteasomal degradation of the domesticated retroelement PEG10

  2024cites this paper
• Sleep EEG signatures in mouse models of 15q11.2-13.1 duplication (Dup15q) syndrome

  2024cites this paper
• Ubiquitin system mutations in neurological diseases.

  2024cites this paper
• Reduction of sacsin levels in peripheral blood mononuclear cells as a diagnostic tool for spastic ataxia of Charlevoix–Saguenay

  2024cites this paper
• Hyperactivation of MEK1 in cortical glutamatergic neurons results in projection axon deficits and aberrant motor learning

  2024cites this paper
• ArcKR expression modifies synaptic plasticity following epileptic activity: Differential effects with in vitro and in vivo seizure‐induction protocols

  2024cites this paper
• Formation of cognitive processes in children with autism. Part II. Genetic mechanisms

  2024cites this paper
• Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo

  2024cites this paper
• Integration of CTCF Loops, Methylome, and Transcriptome in Differentiating LUHMES as a Model for Imprinting Dynamics of the 15q11-q13 Locus in Human Neurons

  2024cites this paper
• Do metabolic deficits contribute to sleep disruption in monogenic intellectual disability syndromes?

  2024cites this paper
• Functional analysis of the ube3a response in Japanese flounder (Paralichthys olivaceus) to CSBV infection.

  2024cites this paper
• Human Virus-Like Proteins: Implications for Gene Therapy.

  2024cites this paper
• Widespread Gene Editing in the Brain via In Utero Delivery of mRNA Using Acid-Degradable Lipid Nanoparticles

  2024cites this paper
• Human pluripotent stem cell (hPSC)-derived models for autism spectrum disorder drug discovery

  2024cites this paper
• Pin1 promotes human CaV2.1 channel polyubiquitination by RNF138: pathophysiological implication for episodic ataxia type 2

  2024cites this paper
• Microplastics/nanoplastics and Neurological Health: An Overview of Neurological Defects and Mechanisms.

  2024cites this paper
• Differences in structure, dynamics, and zinc coordination between isoforms of human ubiquitin ligase UBE3A

  2024cites this paper
• Structural Variations Identified in Patients with Autism Spectrum Disorder (ASD) in the Chinese Population: A Systematic Review of Case-Control Studies

  2024cites this paper
• Understanding the role of AMPA receptors in autism: insights from circuit and synapse dysfunction

  2024cites this paper
• Neuropsychopharmacology: Shaping Neuroplasticity through Arc/Arg3.1 Modulation.

  2024cites this paper
• Integration of CTCF loops, methylome, and transcriptome in differentiating LUHMES as a model for imprinting dynamics of the 15q11-q13 locus in human neurons

  2024cites this paper
• Undiagnosed rare disease clinic identifies a novel UBE3A variant in two sisters with Angelman syndrome: The end of a diagnostic odyssey

  2024cites this paper
• Behavioral and Psychiatric Disorders in Syndromic Autism

  2024cites this paper
• Need of orthogonal approaches in neurological disease modeling in mouse

  2024cites this paper
• Prenatal Exposure to Azadiradione Leads to Developmental Disabilities

  2024cites this paper
• Enhancing mRNA Interactions by Engineering the Arc Protein with Nucleocapsid Domain.

  2024cites this paper
• Sexually dimorphic phenotypes and the role of androgen receptors in UBE3A-dependent autism spectrum disorder

  2024cites this paper
• Disease-associated polyalanine expansion mutations impair UBA6-dependent ubiquitination

  2024cites this paper
• UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes

  2024cites this paper
• Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids

  2024cites this paper
• Anatomical and molecular development of the human primary visual cortex

  2024cites this paper
• mRNA nuclear retention reduces AMPAR expression and promotes autistic behavior in UBE3A-overexpressing mice

  2024cites this paper
• The modulatory role of bone morphogenetic protein signaling in cerebellar synaptic plasticity

  2024cites this paper
• A de novo ARIH2 gene mutation was detected in a patient with autism spectrum disorders and intellectual disability

  2024influential citation
• Protein Folding and Molecular Basis of Memory: Molecular Vibrations and Quantum Entanglement as Basis of Consciousness.

  2023cites this paper
• A PSD-95 peptidomimetic mitigates neurological deficits in a mouse model of Angelman Syndrome.

  2023cites this paper
• Synaptic Aspects of the Pathogenesis of Autism, Amyotrophic Lateral Sclerosis, and Alzheimer’s Disease

  2023cites this paper
• Arc protein, a remnant of ancient retrovirus, forms virus-like particles, which are abundantly generated by neurons during epileptic seizures, and affects epileptic susceptibility in rodent models

  2023cites this paper
• INHERITED 15Q DUPLICATION IN THREE NOT RELATED UKRAINIAN FAMILIES

  2023cites this paper
• A Critical Review of the Impact of Candidate Copy Number Variants on Autism Spectrum Disorder.

  2023cites this paper
• UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies

  2023influential citation
• Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway

  2023cites this paper
• Restoring calcium homeostasis in Purkinje cells arrests neurodegeneration and neuroinflammation in the ARSACS mouse model

  2023cites this paper
• The Role of MEF2 Transcription Factor Family in Neuronal Survival and Degeneration

  2023cites this paper
• A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman Syndrome mice.

  2023cites this paper
• Evidence for parent-of-origin effects in autism spectrum disorder: a narrative review

  2023cites this paper
• Maintenance of a short-lived protein required for long-term memory involves cycles of transcription and local translation.

  2023cites this paper
• Mechanisms and Functions of Activity-Regulated Cytoskeleton-Associated Protein in Synaptic Plasticity

  2023cites this paper
• Imbalanced expression of cation-chloride cotransporters as a potential therapeutic target in an Angelman syndrome mouse model

  2023cites this paper
• Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease

  2023cites this paper
• Understanding neurodevelopmental proteasomopathies as new rare disease entities: A review of current concepts, molecular biomarkers, and perspectives

  2023cites this paper
• Arc expression regulates long‐term potentiation magnitude and metaplasticity in area CA1 of the hippocampus in ArcKR mice

  2023cites this paper
• Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling

  2023cites this paper
• Updates on the Physiopathology of Group I Metabotropic Glutamate Receptors (mGluRI)-Dependent Long-Term Depression

  2023cites this paper
• Characterizing the Neuron-Glial Interactions by the Co-cultures of Human iPSC-Derived Oligodendroglia and Neurons.

  2023cites this paper
• Stem cell models of Angelman syndrome

  2023cites this paper
• Azadiradione up-regulates the expression of parvalbumin and BDNF via Ube3a.

  2023cites this paper
• Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids

  2023cites this paper
• Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration

  2022cites this paper
• A differential effect for tau isoforms and mutants in decreasing the stability of Arc

  2022cites this paper
• AlphaFold predicted structure of the Hsp90-like domains of the neurodegeneration linked protein sacsin reveals key residues for ATPase activity

  2022cites this paper
• Activity-regulated E3 ubiquitin ligase TRIM47 modulates excitatory synapse development

  2022cites this paper
• Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia

  2022cites this paper
• Arc ubiquitination regulates endoplasmic reticulum-mediated Ca2+ release and CaMKII signaling

  2022cites this paper
• Excessive Protein Accumulation and Impaired Autophagy in the Hippocampus of Angelman Syndrome Modeled in Mice.

  2022cites this paper
• Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications

  2022cites this paper
• Arc weakens synapses by dispersing AMPA receptors from postsynaptic density via modulating PSD phase separation

  2022cites this paper
• Pharmacotherapeutic management of seizures in patients with Angleman Syndrome

  2022cites this paper
• A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder

  2022cites this paper
• 'Arc'-hitecture of normal cognitive aging.

  2022cites this paper
• Role of the DUB enzyme USP7 in dendritic arborization, neuronal migration, and autistic-like behaviors in mice

  2022cites this paper
• Autism Spectrum Disorder Genes: Disease-Related Networks and Compensatory Strategies

  2022cites this paper
• Neuroligin-3 confines AMPA receptors into nanoclusters, thereby controlling synaptic strength at the calyx of Held synapses

  2022cites this paper